Some drug patents in the Biden administration's crosshairs
Listen now
Description
The White House says it can use "march-in rights" to seize patents for certain medicines partly developed with federal funds. Host Katherine Ellen Foley talks with POLITICO White House Correspondent Adam Cancryn about how the move could give the president another tool in his effort to lower drug prices.
More Episodes
Artificial intelligence is changing the way doctors practice, but also how the health care business runs. Host Chelsea Cirruzzo talks with POLITICO health care reporter Daniel Payne about the ways AI is already used across the medical landscape and how regulators are responding.
Published 12/22/23
Published 12/22/23
As federal officials scramble to regulate artificial intelligence in health care, HHS has already become one of the top federal agencies using the technology. Host Kelly Hooper talks with POLITICO health reporter Chelsea Cirruzzo about some of the 80 implemented or planned uses of AI by HHS...
Published 12/21/23